Cargando…
Current Evidence and Future Perspectives on Pharmacological Treatment of Calcific Aortic Valve Stenosis
Calcific aortic valve stenosis (CAVS), the most common heart valve disease, is characterized by the slow progressive fibro-calcific remodeling of the valve leaflets, leading to progressive obstruction to the blood flow. CAVS is an increasing health care burden and the development of an effective med...
Autores principales: | Donato, Maristella, Ferri, Nicola, Lupo, Maria Giovanna, Faggin, Elisabetta, Rattazzi, Marcello |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7663524/ https://www.ncbi.nlm.nih.gov/pubmed/33158204 http://dx.doi.org/10.3390/ijms21218263 |
Ejemplares similares
-
The Emerging Role of Nutraceuticals in Cardiovascular Calcification: Evidence from Preclinical and Clinical Studies
por: Donato, Maristella, et al.
Publicado: (2021) -
Role for Galectin‐3 in Calcific Aortic Valve Stenosis
por: Sádaba, J. Rafael, et al.
Publicado: (2016) -
Celecoxib Is Associated With Dystrophic Calcification and Aortic Valve Stenosis
por: Bowler, Meghan A., et al.
Publicado: (2019) -
Lipoprotein(a) as Orchestrator of Calcific Aortic Valve Stenosis
por: Schnitzler, Johan G., et al.
Publicado: (2019) -
Antiphospholipid antibodies in patients with calcific aortic valve stenosis
por: Plunde, Oscar, et al.
Publicado: (2022)